BUHLMANN Diagnostic Corp – New Partner Channel Agreement with Roche Diagnostics.
Category: Uncategorized
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. CALEX® Cap Stool Preparation Device- for fecal Calprotectin & fecal Pancreatic Elastase The BÜHLMANN CALEX® Cap is designed to provide convenient and safe stool extraction of multiple analytes. The optimized dilution of stool sample yields maximum extraction efficiency and analyte
Continue Reading
BÜHLMAN sCAL turbo assay is for Research Use Only. Not for use in diagnostic procedures in the US. BÜHLMANN sCAL® turbo Serum Calprotectin (sCAL, aka: myeloid-related protein 8/14 (MRP8/14), S100A8/A9, calprotectin) is a powerful biomarker to study the inflammatory status of a subject whether it is a classical autoimmune mediated Rheumatoid Arthritis (RA) or a rare
Continue Reading
Next Generation Food Allergy Drug Development Summit, July 20-22, 2021: BUHLMANN is proud to partner with this event, specifically focused on enhancing the food allergy drug development approach. Flow CAST® is the standardized, proven & assessable Basophil Activation Test. An accurate biomarker of an allergic reaction… in a vial. BUHLMANN Allergy Assay Offering Diagnosis of
Continue Reading
BÜHLMANN fCAL® turbo or BÜHLMANN fPELA® turbo BÜHLMANN fCAL® turbo or BÜHLMANN fPELA® turbo currently have validated IVD application notes for use in the United States on the clinical chemistry analyzers listed below. These allow for the FDA 510(k) cleared fecal calprotectin or FDA Exempt fecal pancreatic elastase to be tested on the Roche cobas®
Continue Reading
US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Van den Bergh, P.Y.K., et al., 2021: European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of
Continue Reading
US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Herrendorff R et , 2017: Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen specific treatment option for anti-MAG neuropathy. PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1619386114 DOI: 10.1073/pnas.1619386114
Continue Reading
US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Toscano G et al., 2020; Guillain-Barré Syndrome Associated with SARS-CoV-2 (Letter to the editor); NEJM; April 27, 2020 DOI: 10.1056/NEJMc2009191 Continue Reading Delmont E et
Continue Reading
